CollPlant Biotechnologies Ltd.
CLGN
$0.37
$0.000.27%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | 17.30% | 20.50% | 65.39% | 17.30% | |
| Total Depreciation and Amortization | -10.74% | -12.26% | -12.86% | -14.79% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -109.04% | -55.56% | -7.23% | -3.01% | |
| Change in Net Operating Assets | 148.35% | 168.70% | -239.27% | -110.74% | |
| Cash from Operations | 15.27% | 37.88% | 64.13% | -47.72% | |
| Capital Expenditure | 74.58% | 98.51% | 89.02% | 74.24% | |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -98.53% | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | -- | 100.00% | |
| Cash from Investing | 74.14% | 98.84% | 90.24% | 84.41% | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -110.00% | 133.90% | 100.81% | -69.85% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 14.62% | 116.24% | 65.96% | -37.49% | |